Characterizing Mechanisms of Response and Resistance to Immune Checkpoint Inhibitor Therapy Using...
Published 2021-05-10Download video
Recommendations
-
1:32:16 An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar
-
13:24 Flow Cytometry Analysis
-
03:29 PD-L1/PD-1 Pathway: A Security Checkpoint
-
55:10 CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine
-
44:56 Immune Checkpoint Blockade in Cancer Therapy
-
1:26:39 Standing on the Shoulders of Giants
-
51:40 3. Structures of Amino Acids, Peptides, and Proteins
-
02:07 Immune Checkpoint Inhibitors, The Next Generation Cancer Therapy - Creative Biolabs
-
1:14:15 Managing nerves, anxiety, and burnout | Jonny Miller (Nervous Systems Mastery)
-
1:28:26 Cancer Metabolism: From molecules to medicine
-
1:19:51 J.S. Bach: The Violin Concertos
-
2:52:21 Binding Site Predictions and Analysis & Theory, principles, methods of molecular docking
-
12:12 Immune Checkpoint Proteins
-
09:15 Caffeine, Health, and the Human Body
-
25:04 Rethinking BPD: A Clinician's View
-
55:14 “Drawing Causality from Observational Data in Healthcare:..."
-
01:05 Limitations in immune checkpoint inhibitors in treating gastric cancer
-
22:08 Cancer Immunotherapy: 2023 Research and a Look Ahead with Nina Bhardwaj, MD, PhD
-
2:17:47 Antibiotics
-
05:33 Cancer Immune Checkpoint Inhibitors
Similar videos
-
44:15 June 7, 2021 | Investigating Mechanisms of Response & Resistance to Immune Checkpoint Therapy
-
03:48 Overcoming resistance to immune checkpoint inhibitors in NSCLC
-
01:45 Mechanisms of resistance to checkpoint inhibitors in melanoma
-
01:20 Resistance to immune checkpoint blockade in patients with cSCC
-
02:05 Immunotherapy resistance mechanisms and predicting NMIBC patient immune responses.
-
02:47 Mechanisms of acquired resistance against immunotherapy
-
44:01 Characterization of immune checkpoint expression & infiltrating immune cells in TME by RNAscope ISH
-
56:25 Dissecting Toxicities of Immune Checkpoint Inhibitors with Dr. Douglas Johnson, M.D., MSCI
-
03:15 (Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2
-
30:23 Lecture looking ahead - Potential barriers to immune checkpoint inhibitors use in MIBC
-
00:53 Discovering immunotherapy resistance mechanisms using single-cell technologies
-
1:04:06 Modeling Mechanisms of Therapeutic Response and Resistance
-
07:35 (Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors - Part 1
-
05:03 Tumour immunology and immunotherapy
-
1:30:01 Defining Mechanisms and Biomarkers of Sensitivity & Resistance To Anti-Cancer Treatments
-
25:42 Differential Tumour Microenvironment Response to PD 1 Checkpoint Inhibition - By Shinjini
-
27:57 Primary and Acquired Resistance to Cancer Immunotherapy